{
    "nctId": "NCT01479101",
    "briefTitle": "NBRST: Prospective Neo-adjuvant REGISTRY Trial",
    "officialTitle": "Prospective Neo-adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial (NBRST) (Pronounced \"in Breast\")",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1142,
    "primaryOutcomeMeasure": "Chemosensitivity as defined by pCR",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with histologically proven breast cancer, who have started or are scheduled to start neo-adjuvant chemotherapy therapy or neo-adjuvant hormone therapy, after successful MammaPrint assay\n* Age 18-90\n* Written informed consent\n\nExclusion Criteria:\n\n* Patients who have had excisional biopsy or axillary dissection Patients with confirmed distant metastatic disease\n* Tumor sample shipped to Agendia with \u2264 30% tumor cells or that fails QA or QC criteria\n* Patients who have had any prior chemotherapy, radiotherapy, or endocrine therapy for the treatment of breast cancer\n* Any serious uncontrolled intercurrent infections, or other serious uncontrolled concomitant disease",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}